Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes
Andrew R. DiNardo, Tanmay Gandhi, Jan Heyckendorf, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 3, pp. 2102263-2102263
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Multidrug-resistant tuberculosis
Keertan Dheda, Fuad Mirzayev, Daniela María Cirillo, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 64
Recent advances in the treatment of tuberculosis
Ilaria Motta, Martin J. Boeree, Dumitru Chesov, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 9, pp. 1107-1114
Open Access | Times Cited: 35
Regulation of proteostasis and innate immunity via mitochondria-nuclear communication
Sookyung Kim, Theresa Ramalho, Cole M. Haynes
The Journal of Cell Biology (2024) Vol. 223, Iss. 3
Open Access | Times Cited: 10
TCA metabolism regulates DNA hypermethylation in LPS and Mycobacterium tuberculosis –induced immune tolerance
Abhimanyu Abhimanyu, Santiago Carrero Longlax, Tomoki Nishiguchi, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 41
Open Access | Times Cited: 7
The evolving biology of Mycobacterium tuberculosis drug resistance
R. Mark Jones, Kristin N. Adams, Hassan E. Eldesouky, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 24
Reinventing the human tuberculosis (TB) granuloma: Learning from the cancer field
Senait Ashenafi, Susanna Brighenti
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
MicroRNA–mRNA networks are dysregulated in opioid use disorder postmortem brain: Further evidence for opioid-induced neurovascular alterations
Sandra L. Grimm, Emily Méndez, Laura Stertz, et al.
Frontiers in Psychiatry (2023) Vol. 13
Open Access | Times Cited: 14
Inflammatory immune profiles associated with disease severity in pulmonary tuberculosis patients with moderate to severe clinical TB or anemia
Senait Ashenafi, Marco Giulio Loreti, Amsalu Bekele, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
BCG-induced DNA methylation changes improve COVID19 vaccine immunity without decreasing the risk for COVID19 infection
Santiago Carrero Longlax, Kent J. Koster, Ashish M. Kamat, et al.
Open Forum Infectious Diseases (2025)
Open Access
A novel method for detecting Lipoarabinomannan in urine with the promise of meeting the WHO target product profile for the diagnosis of tuberculosis
Katharina B. Budde, Christoph Lange, Maja Reimann, et al.
Tuberculosis (2025) Vol. 152, pp. 102619-102619
Open Access
Microenvironments of tuberculous granuloma: advances and opportunities for therapy
G. R. F. Krueger, Shah Faisal, Anca Dorhoi
Frontiers in Immunology (2025) Vol. 16
Open Access
Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management
Nguyen Quang Thu, Nguyen Tran Nam Tien, Nguyen Thi Hai Yen, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 14, Iss. 1, pp. 16-38
Open Access | Times Cited: 8
Underwhelming or Misunderstood? Genetic Variability of Pattern Recognition Receptors in Immune Responses and Resistance to Mycobacterium tuberculosis
Jean-Yves Dubé, Vinicius M. Fava, Erwin Schurr, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 17
Cell state transition analysis identifies interventions that improve control of Mycobacterium tuberculosis infection by susceptible macrophages
Shivraj M. Yabaji, Oleksii S. Rukhlenko, Sujoy Chatterjee, et al.
Science Advances (2023) Vol. 9, Iss. 39
Open Access | Times Cited: 7
Immunopathology in human pulmonary tuberculosis: Inflammatory changes in the plasma milieu and impaired host immune cell functions
Hubert Senanu Ahor, Monika M. Vivekanandan, Jean De Dieu Harelimana, et al.
Immunology (2024) Vol. 172, Iss. 2, pp. 198-209
Open Access | Times Cited: 2
AITeQ: a machine learning framework for Alzheimer’s prediction using a distinctive five-gene signature
Ishtiaque Ahammad, Anika Bushra Lamisa, Arittra Bhattacharjee, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 4
Open Access | Times Cited: 2
Viewpoint of multi-omics potential in tuberculosis research: identifying biomarkers for biomanufacturing of efficient control tools
Isaac Darko Otchere, Samuel Yaw Aboagye, Patrick Kobina Arthur, et al.
Frontiers in Tropical Diseases (2024) Vol. 5
Closed Access | Times Cited: 2
Multiomic Investigations into Lung Health and Disease
Sarah E. Blutt, Cristian Coarfa, Josef Neu, et al.
(2023)
Open Access | Times Cited: 4
Endotypes of Paediatric Cough—Do They Exist and Finding New Techniques to Improve Clinical Outcomes
Hannah E. O’Farrell, Hing Cheong Kok, Suhani Goel, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 756-756
Open Access | Times Cited: 1
Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles
Stephen H. Gillespie, Andrew R. DiNardo, Sophia B. Georghiou, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 9, pp. 100869-100869
Closed Access | Times Cited: 1
Monocyte transcriptome signatures of inflammation and enhanced neutrophil recruitment characterize immunopathology in the blood of TB patients
Hubert Senanu Ahor, Monika M. Vivekanandan, Ernest Adankwah, et al.
Journal of Infection (2024) Vol. 89, Iss. 6, pp. 106359-106359
Open Access | Times Cited: 1
Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.
Francine Ntoumi, Eskild Petersen, Peter Mwaba, et al.
International Journal of Infectious Diseases (2022) Vol. 124, pp. S69-S74
Open Access | Times Cited: 4
Distinct contributions of the innate immune receptors TLR2 and RP105 to formation and architecture of structured lung granulomas in mice infected with Mycobacterium tuberculosis
Meg L. Donovan, Helle Bielefeldt‐Ohmann, Rachel F. Rollo, et al.
Immunology (2022) Vol. 169, Iss. 1, pp. 13-26
Open Access | Times Cited: 3
Beyond the Clinic: The Activation of Diverse Cellular and Humoral Factors Shapes the Immunological Status of Patients with Active Tuberculosis
Nancy Liliana Tateosian, María Paula Morelli, Joaquín Miguel Pellegrini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5033-5033
Open Access | Times Cited: 1
Differences in PPD- and mitogen-induced T-cell activation marker expression characterize immunopathology in acute tuberculosis patients
Isaac Acheampong, Difery Minadzi, Edwin Ferguson Laing, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2024) Vol. 43, Iss. 3, pp. 611-616
Open Access
Page 1 - Next Page

Scroll to top